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CLINICAL INVESTIGATION
Potential Value of Impaired Cognition in Stroke Prediction: A
U.K. Population-Based Study
Blossom C. M. Stephan, PhD,*†a Kathryn Richardson, PhD,‡a George M. Savva, PhD,‡
Fiona E. Matthews, PhD,* Carol Brayne, MD,§b and Vladimir Hachinski, MD, PhD¶b
OBJECTIVES: To determine whether the association
between impaired cognition and greater risk of incident
stroke is also observed when cognitive impairment is
defined using different criteria for mild cognitive impair-
ment (MCI).
DESIGN: Prospective cohort study with 10 years of fol-
low-up.
SETTING: Large multicentre study in the United King-
dom.
PARTICIPANTS: Individuals (aged 64–105) from the
Medical Research Council Cognitive Function and Ageing
Study (N = 13,004). From this, a subsample of 2,640 indi-
viduals was selected based on age, center, and cognitive
ability to undergo a detailed cognitive assessment.
MEASUREMENTS: Information on sociodemographic
characteristics, health, cognition, and functional ability
was collected in an interview. The Geriatric Mental State
Automated Geriatric Examination for Computer Assisted
Taxonomy and the Cambridge Cognitive Examination
were used to determine cognitive status. Stroke incidence
was derived from self-report, informant report, and death
certificates. Participants were divided into no, mild, moder-
ate, and severe cognitive impairment according to their
baseline Mini-Mental State Examination (MMSE) score.
MCI criteria were used to classify persons into four
groups: no cognitive impairment, MCI, severe impairment
(i.e. other cognitive impairment no dementia: OCIND)
and dementia.
RESULTS: Over 10 years, 703 incident strokes occurred.
Lower MMSE score at baseline was associated with
greater risk of incident stroke. When cognitive status was
determined according to MCI criteria, those with severe
impairment (odds ratio (OR) = 1.5, 95% confidence inter-
val (CI) = 1.0–2.2) and dementia (OR = 2.6, 95%
CI = 1.6–3.4) had a significantly greater risk of stroke
than those with no cognitive impairment.
CONCLUSION: Criteria for MCI, defined using MMSE
scores or clinical criteria, can capture individuals at greater
stroke risk. The results highlight the need to focus on
stroke risk in individuals even with MCI. J Am Geriatr
Soc 2017.
Key words: mild cognitive impairment (MCI);
stroke; cognitive aging; cohort studies; risk factors in
epidemiology
Stroke has been associated with greater risk of cognitivedecline and dementia,1,2 and impaired cognitive func-
tion has been associated with greater risk of incident
stroke. Older adults (aged ≥65) with cognitive impairment
or dementia have been found to have a risk of developing
stroke that is two to three times as high as that of those
without cognitive impairment.3–15 The association is found
to be independent of stroke risk factors such as hyperten-
sion, smoking, and age. In contrast, no association has
been found in younger adults (aged 48–67).16 Identifica-
tion of individuals with cognitive impairment and at high
risk of stroke would be advantageous for stroke prevention
and could have important implications in terms of the
management of vascular and cognitive disease.
Subjective memory complaints,17 in addition to
impairments in global cognitive function,3,4,8–10,12,18,19
memory,12,19 executive performance,5,11,19 and sensorimo-
tor skills,20 have all been associated with greater risk of
stroke, in some but not all studies.17 There is also some
evidence of racial differences, with higher risks for blacks
than whites, especially for episodic memory, which could
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be due to a higher burden of vascular risk factors, higher
prevalence of undiagnosed vascular cognitive impairment,
lower reserve linked to less education, or genetic differ-
ences between blacks and whites, although these require
further investigation.19 Most studies have assessed risk
associated with performance on a single neuropsychologi-
cal test (e.g., Mini Mental State Examination: MMSE,
Trail-Making Test, verbal fluency tasks; see14 for a sum-
mary of the tests used), which may be too restrictive. Fur-
ther, most neuropsychological tests that have been used to
explore associations, apart from the MMSE, are not typi-
cally used in clinical settings, raising questions of applica-
bility for identifying individuals at high risk of stroke for
primary or secondary prevention.14
Clinical criteria for mild cognitive impairment (MCI)
identify individuals at risk of dementia. MCI defined using
criteria for cognitive impairment no dementia has been asso-
ciated with risk of stroke,6,21,22 but there are numerous defi-
nitions for MCI23 that vary in their inclusion criteria, and
whether the association is consistent depending on how
MCI is defined is not known. No study has tested whether
MCI defined using the stricter, more widely applied Mayo
Clinic criteria24 is also associated with stroke risk.
The aim of this study was to examine whether cogni-
tive status predicts incident stroke using a population-
based framework including the link between incident
stroke and cognition measured using the MMSE25 and the




Data were from the Medical Research Council Cognitive
Function and Ageing Study (CFAS). A description of the
study has been published.26 In brief, random samples of indi-
viduals aged 65 and older were selected from the Family
Health Service Authority lists in five areas of England and
Wales: Cambridgeshire, Gwynedd, Newcastle, Nottingham,
and Oxford. Equal numbers were randomly selected from
each age group (65–74, ≥75) to produce an overall sample
size of approximately 2,500 people in each area. Recruitment
took place between 1991 and 1994. In total, 13,004 partici-
pants (aged 64–105; mean education 10.0  2.3 years, range
0–34 years) completed a standardized screening interview at
their place of residence. At baseline screening, information
was collected on sociodemographic status, health (including
self-report of chronic conditions), and cognitive performance
(measured using the MMSE and items about organic-type
mental symptoms from the Geriatric Mental State Automated
Geriatric Examination for Computer Assisted Taxonomy
(AGECAT)).27
Of the 13,004 individuals that completed the screen-
ing interview, 2,640 (20.3%) were selected based on age,
center, and cognitive ability (weighted toward older indi-
viduals and more cognitively frail individuals, including
those with an AGECAT rating case level of ≥3, plus all
those who had incomplete MMSE scores or MMSE scores
of ≤21) to complete a more-detailed diagnostic assessment
interview that included the organicity sections of the AGE-
CAT28 and the Cambridge Cognitive Examination
(CAMCOG).29 The selection strategy therefore targeted all
potential dementia cases in addition to a random sample
of those without dementia.
Follow-Up
Individuals who underwent further assessment have been
re-interviewed approximately every 2 years. Data from
baseline and 2, 6, and 10-year follow-ups were used in this
analysis (CFAS Data Version 9.0).
Ethics
CFAS has local and multicenter ethics committee approval.
All participants, or their informant, gave fully informed
consent before the interview.
Neuropsychological Evaluation
Global cognition was assessed using the MMSE. Based on
MMSE scores, the following groups were defined: no (27–
30), mild (24–26), moderate (19–23), and severe (0–18)
impairment. These cut-offs were derived from previous
research in CFAS that found that MMSE scores ranging
from 24 to 26 had high predictive accuracy for 2-year inci-
dent dementia.25,30
Domain-specific cognitive function was assessed using
the CAMCOG with three items excluded: items on tactile
recognition of coins (10 pence, 5 pence) and calculation of
their sum (omitted because UK coins had recently changed)
and recognition of two people in the room (omitted because
this item was originally intended for use in a hospital and is
not relevant to a home setting). A total score assessing over-
all ability was calculated (range 0–103). Subscale scores
were derived for memory (learning, recent, remote) and
nonmemory (language comprehension and expression, ori-
entation, perception, praxis, abstraction and attention and
calculation) domains. Summing scores only from the mem-
ory or nonmemory subscales created composite scores.
Because the CAMCOG scores were not normally dis-
tributed, impairment was defined using percentiles (the 16th
centile to estimate a cut-off score approximately one stan-
dard deviation below the mean) adjusted for age.
Dementia
Dementia was defined as an AGECAT organicity rating
case level of 3 or greater, which has been found to be simi-
lar to dementia diagnosed using the Diagnostic and Statis-
tical Manual of Mental Disorders, Third Edition,
Revised.31
Physical Function
A modified version of the Townsend Disability Scale was
used to assess activities of daily living (ADL) and instru-
mental activities of daily living (IADL) performance.32
Individuals were classified as not impaired if no help was
needed with washing, hot meals, shoes and socks, heavy
housework, or shopping and carrying heavy bags, and the
individual could get around outside; mildly impaired if the
person required regular help with heavy housework or
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shopping and carrying heavy bags; or severely impaired if
the person was housebound or required help at least sev-
eral times per week with washing, cooking, and dressing.
Diagnosing MCI
Individuals were classified as having MCI using the follow-
ing criteria24: no dementia; subjective or informant com-
plaint of memory loss (defined as a positive response to
one or more of the following: Have you had any difficulty
with your memory? Have you tended to forget things
recently? or Has he or she had any difficulty with his or
her memory?); essentially preserved general cognitive func-
tion (MMSE score ≥22); no or only mild functional
impairment; and, objective memory or nonmemory impair-
ment (from the CAMCOG memory and nonmemory
scores, outlined above). Individuals without dementia with
normal general cognitive function (MMSE score ≥22), no
or mild functional impairment, and preserved memory and
nonmemory test performance were classified as having no
cognitive impairment (NCI). All nonnormal individuals
who failed to fulfill criteria for MCI (e.g., MMSE score
<22, severe functional impairment and no dementia) were
classified as having other cognitive impairment no demen-
tia (OCIND). A detailed description of the OCIND group
has been published previously.33
Stroke Assessment
Stroke incidence was determined from three sources: self-
report and informant report at each interview and death
certificates. Participants were asked whether they had ever
had a stroke that required medical attention. A stroke was
reported from the death certificate if an International Clas-
sification of Diseases, Ninth Revision, code of 430–438
was recorded. Based on the follow-up interviews, three
waves were defined to map stroke incidence over time:
Wave 1 (baseline to 2-year follow-up), Wave 2 (2- to 6-
year follow-up), and Wave 3 (6- to 10-year follow-up).
This ensured that there were sufficient numbers of respon-
dents at the end of the wave with incident stroke. To
ascertain incident stroke, at the start of each wave, those
reporting a history of stroke were excluded. Individuals
with incomplete stroke history were also excluded. A full
description of the CFAS interview schedule and the defini-
tion of each wave are shown in Figure S1 and Table S1.
Covariates
Information on sex, age, education (<10 vs ≥10 years),
and vascular risk factors (self-reported history of heart
attack, diabetes mellitus, hypertension, angina pectoris,
and smoking status (never, past, current)) was collected at
each interview wave.
Statistical Analysis
All analyses were completed using Stata version 14 (Stata
Corp., College Station, TX). Participants reporting a history
of stroke at baseline or with missing cognition measures
were excluded. Logistic regression was used to calculate
odds ratios (ORs) and 95% confidence intervals (CIs) for
the association between cognition and incident stroke over
the three waves using two models: Model 1 (unadjusted for
covariates) and Model 2 (adjusted for age, sex, education,
wave, heart attack, diabetes mellitus, hypertension, angina
pectoris, smoking status). A test for trend in ORs was also
conducted. Interactions were tested between sex and the
association with cognition and incident stroke.
Because of the sampling strategy and attrition during
the study (excluding death), participants in each wave were
back-weighted to the population using inverse probability
weighting. The weights were defined as the inverse probabil-
ities of being included in each wave according to age, sex,
education, sampling strategy, and cognitive status.
RESULTS
MMSE Analysis
Detailed flow of participants included in the MMSE analysis
is shown in Figure S2. Of the 11,829 participants with no
history of stroke at the start of Wave 1, 2,467 (21%) were
lost to follow-up; of the 3,558 with no history of stroke at
the start of Wave 2, 674 (19%) were lost to follow-up; and
of the 2,046 with no history of stroke at the start of Wave
3, 333 (16%) were lost to follow-up. One hundred and
thirty-three (1%), 86 (2%), and 86 (4%) with incomplete
stroke history and 428 (3%), 151 (4%), and 111 (5%) with
incomplete MMSE scores at the start of each wave were
excluded. The median time between interviews in each wave
was 2.0 (interquartile range (IQR) 2.0–2.1), 3.3 (IQR 2.8–
3.6) and 4.8 (IQR 4.4–5.1) years. Mortality in each wave
was 11%, 20%, and 32%. Seven hundred and three inci-
dent cases of stroke were identified over the three waves
(387 from interviews, 316 from death certificates). The
sociodemographic characteristics and cognitive status of
participants in each wave are presented in Table 1. Educa-
tional attainment was higher in groups with higher MMSE
at baseline (Table S2), so it was controlled in multivariate
analysis. Those who dropped out or died were older and
more cognitively impaired at baseline (Table S3), and these
factors are included in multivariate models.
For this analysis there were 246, 183, 167, and 107
incident stroke cases in the highest to lowest MMSE
groups, respectively (across waves). Lower MMSE scores
were associated with greater incidence of stroke (Table 2).
A full multivariate model showing the effects of all covari-
ates is shown in Table S4. The trend for all models was
significant (P < .001). The association between MMSE
score and incident stroke did not vary according to sex
(OR = 0.72, 95% CI = 0.59–0.90). Participants excluded
because they had missing MMSE scores at the start of each
wave reported 50 incident strokes and had a significantly
higher rate of stroke (OR = 2.5, 95% CI = 1.6–4.0).
MCI Analysis
Detailed flow of participants included in the MCI analysis
is shown in Figure S3. For the MCI analysis, 2,237 partici-
pants had no history of stroke at the start of Wave 1,
2,623 had no history of stroke at the start of Wave 2, and
1,483 had no history of stroke at the start of Wave 3.
Twenty-eight (2%), 84 (3%), and 68 (5%) with
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incomplete stroke histories and 96 (4%), 163 (6%), and
47 (3%) with missing MCI classification at the start of
each wave were excluded. Of the 219 participants with
MCI who died or completed Wave 1 43 had amnestic
MCI, 108 had nonamnestic MCI, and 68 had mixed MCI.
The percentage of participants alive but missing stroke
information at the end of each wave was 27%, 25%, and
19%, leaving 1,627, 1,897, and 1,658 participants in the
analysis for Waves 1, 2, and 3, respectively. The median
time between interviews in each wave was 2.1 (IQR 2.0–
2.2), 2.8 (IQR 2.3–3.2), and 4.8 (IQR 4.4–5.1) years. Mor-
tality in each wave was 19%, 26%, and 37%, respectively.
Three hundred and eighty-two incident cases of stroke were
identified over the three waves. The sociodemographic char-
acteristics and cognitive status of the participants in each
wave are presented in Table 3, and baseline characteristics
according to MCI group are shown in Table S5.
For this analysis, there were 98 incident strokes in par-
ticipants with NCI, 27 in those with MCI, 79 in those with
OCIND, 64 in those with ADL impairment, and 114 in
those with dementia (across waves). The odds of incident
stroke were greater with poorer cognitive function
(P < .001). Participants with dementia and OCIND had
significantly greater incidence of stroke than those with no
cognitive impairment (Table 4; full multivariate model
shown in Table S6). There was a greater incidence of
stroke in the MCI group, but the result was not statistically
significant. There was a potential interaction between sex
and incident stroke in persons with dementia (P = .07).
Women with dementia (OR = 3.0, 95% CI = 1.8–5.2) had
a higher risk of incident stroke than men (OR = 1.2, 95%
CI = 0.6–2.5). The results in men could be because of
reduced statistical power to detect an effect due to the
small number of men; 72% of individuals with dementia
were female (Table S5).
Participants excluded because of missing MCI classifi-
cation at the start of each wave reported 21 strokes. There
was no evidence of an association between missing MCI
classification and stroke incidence (OR = 1.4, 95%
CI = 0.8–2.6).
DISCUSSION
This study explored the association between incident
stroke and cognition stratified according to MMSE score
or defined using criteria for MCI. Consistent with other
studies, a significantly greater risk of stroke was found
with poorer cognitive function. The results highlight the
importance of identification of cognitive decline not only
within the context of neurodegenerative disease (e.g., Alz-
heimer’s disease), but also as a risk factor for cerebrovas-
cular events such as stroke.
Table 1. Participant Characteristics According to Wave












Male 3,781 (42) 1,079 (40) 644 (40)
Female 5,297 (58) 1,650 (60) 984 (60)
Age
65–74 4,599 (51) 1,170 (43) 495 (30)
75–84 3,566 (39) 1,088 (40) 809 (50)
≥85 913 (10) 471 (17) 324 (20)
Education, years
0–9 5,492 (61) 1,753 (65) 1,009 (62)
≥10 3,508 (39) 950 (35) 614 (38)
MMSE score
27–30 5,310 (58) 1,092 (40) 807 (50)
24–26 2,260 (25) 780 (29) 404 (25)
19–23 1,164 (13) 586 (21) 303 (19)
0–18 344 (4) 271 (10) 114 (7)
Vascular risk factorsa
Heart attack 927 (10) 330 (12) 212 (13)
Diabetes mellitus 524 (6) 214 (8) 142 (9)
Hypertension 2,780 (31) 962 (35) 671 (41)
Angina pectoris 1,218 (14) 494 (18) 346 (21)
Smoking statusa
Nonsmoker 3,047 (34) 955 (35) 563 (35)
Former smoker 4,287 (48) 1,304 (48) 799 (49)
Current smoker 1,657 (18) 444 (16) 260 (16)
End of wave
Dead 1,090 (12) 633 (23) 573 (35)
No stroke 952 (10) 541 (20) 487 (30)
Stroke 138 (2) 92 (3) 86 (5)
Alive 7,988 (88) 2,096 (77) 1,055 (65)
No stroke 7,735 (85) 2,022 (74) 995 (61)
Stroke 253 (3) 74 (3) 60 (4)
Numbers refer to those completing each wave with data on MMSE score
at baseline and stroke at follow-up.
aPercentage reported from valid responses.














27–30 246 1.0 P < .001 1.0 P < .001
24–26 183 1.6 (1.3–2.0) <.001 1.4 (1.1–1.8) .01
19–23 167 2.2 (1.8–2.8) <.001 1.6 (1.2–2.1) <.001
0–18 107 4.0 (3.0–5.2) <.001 2.2 (1.6–3.1) <.001
Model 1: unadjusted.
Model 2: adjusted for age, sex, education, wave, heart attack, diabetes mellitus, hypertension, angina pectoris, and smoking status.
OR=odds ratio; CI=confidence interval.
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A greater risk of stroke was found even in the group
with MMSE scores of 24–26 that persisted when adjusting
for confounding factors. These results are consistent with
previous findings linking impaired global cognitive func-
tion with major cerebrovascular events such as stroke and
suggest that poor MMSE performance is a marker for cov-
ert cerebrovascular disease.9,11 These findings highlight the
potential of even subtle, preclinical cognitive deficits as a
possible risk factor for stroke.
In contrast, when cognitive impairment was defined
using MCI criteria, significant effects were found not in par-
ticipants with MCI but in those that these classifications
excluded (e.g., OCIND and dementia). There was also
greater risk of stroke in the MCI group, albeit not statisti-
cally significant, that suggests that the size of the association
was not large and that the statistical power of the study was
too limited to detect small effects. Additional studies in lar-
ger cohorts of individuals with MCI with more stroke cases
are needed to replicate and extend these findings.
The mechanisms underlying the link between cognitive
impairment and risk of stroke are poorly understood. It
has been hypothesized that cognitive decline may represent
early manifestation of vascular disease (or subclinical cere-
brovascular injury)11,12 or poor vascular control (e.g.,
medication use) and risk factor reduction (e.g., physical
activity) in individuals with impaired cognition.6 The
analyses were adjusted for demographic, lifestyle, and
comorbidity variables, and although associations were
attenuated, they remained significant. This suggests that
the associations were independent of the underlying health
status and the health risk behaviors controlled for in the
current analysis.
Strengths and Limitations
In CFAS, stroke was self-reported, so incidence estimates
may reflect bias in memory or awareness of the condition,
but previous studies have found that self-report is reason-
ably accurate in estimating stroke in cohort studies.34 As
with any longitudinal study of aging, there is missing data
because of death and attrition, which can lead to selection
bias. All results were therefore weighted for study design
and attrition. Cognition was measured using the MMSE,
and although the MMSE has limitations (e.g., floor and
ceiling effects), it is one of the most widely used cognitive
screening tools in clinical and research practice. It has also
been found to perform as well as other MCI definitions in
predicting 2-year risk of incident dementia in CFAS.25
Table 3. Participant Characteristics According to Wave











Male 567 (35) 695 (37) 646 (39)
Female 1060 (65) 1202 (63) 1012 (61)
Age
65–74 709 (44) 711 (37) 491 (30)
75–84 589 (36) 768 (40) 816 (49)
≥85 329 (20) 418 (22) 351 (21)
Education, years
0–9 1,023 (67) 1,234 (66) 1,033 (63)
≥10 508 (33) 626 (34) 617 (37)
MCI
No cognitive impairment 465 (29) 696 (37) 837 (50)
MCI 219 (13) 199 (10) 95 (6)
Other cognitive
impairment no dementia
381 (23) 407 (21) 324 (20)
Activity of daily living
impairment, no dementia
246 (15) 290 (15) 245 (15)
Dementia 316 (9) 305 (16) 157 (9)
Vascular risk factorsa
Heart attack 151 (10) 245 (13) 208 (13)
Diabetes mellitus 94 (6) 141 (7) 152 (9)
Hypertension 437 (29) 681 (36) 676 (41)
Angina pectoris 200 (13) 365 (19) 352 (21)
Smoking statusa
Nonsmoker 557 (37) 676 (36) 584 (35)
Former smoker 644 (43) 866 (47) 806 (49)
Current smoker 314 (21) 314 (17) 260 (16)
End of wave
Dead 307 (19) 497 (26) 611 (37)
No stroke 266 (16) 420 (22) 515 (31)
Stroke 41 (3) 77 (4) 96 (6)
Alive 1,320 (81) 1,400 (74) 1,047 (63)
No stroke 1,263 (78) 1,349 (71) 987 (60)
Stroke 57 (4) 51 (3) 60 (4)
aPercentage reported from valid responses.













No cognitive impairment 98 1.0 P < .001 1.0 P < .001
MCI 27 1.2 (0.7–2.2) .46 1.6 (0.9–2.8) .15
Other cognitive impairment
no dementia
79 1.5 (1.1–2.1) .02 1.5 (1.0–2.2) .03
Dementia 114 3.8 (2.7–5.2) <.001 2.3 (1.6–3.4) <.001
Model 1: unadjusted.
Model 2: adjusted for age, sex, education, wave, heart attack, diabetes mellitus, hypertension, angina pectoris, and smoking status.
OR=odds ratio; CI=confidence interval.
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Therefore, the current study investigated whether different
MMSE score categories are associated with risk of stroke.
In addition, the associations were tested using more clini-
cally based criteria, including the definition for MCI. Nei-
ther pure amnestic nor nonamnestic MCI were
investigated because they are rare in CFAS and therefore
have limited statistical power.35
CONCLUSION
It is possible that individuals with cognitive decline could
be benefit from careful screening and management of
vascular risk factors to prevent occurrence not only of
dementia, but also of stroke. An opportunity for further
research is the development of accurate models for stroke
risk prediction in individuals with cognitive impairment so
that high-risk individuals can be targeted for stroke
prevention.
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